Exact Sciences Corp.
|Market Cap (Intraday)||19.18B|
|2yr Forward PE||N/A|
Exact Sciences Corp. Stock, NASDAQ:EXAS
EXACT Sciences Corp. is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. The company was founded on February 10, 1995 and is headquartered in Madison, WI.